Clearmind Medicine CMND
NASDAQ CMND
$5.99 -0.13 (-2.04%)
As of: Oct 21, 2026 · 3:52 PM EDT

Clearmind Medicine (CMND) Operating Margin (2023)

Updated

Clearmind Medicine's Operating Margin came in at -4180.53% for FY2022 (year ended Oct 31, 2022), down 1568.02 percentage points from -2612.51% in FY2021.

Analysis

Clearmind Medicine (CMND) Operating Margin (2023) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Operating Margin at -2612.51% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Clearmind Medicine 9,526.05 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2023 -6,703.75%
API Access

Clearmind Medicine Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CMND&period=max&api_key=YOUR_API_KEY